Physician profile
Muhammad Usman
NPI 1710373816
$1,747.86
in general payments reported to CMS, 2019-2025
19 companies · $719 in 2025
The $719 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $419 · 2024: $610 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $422.15 | 2023-2025 | Accrufer |
| Lilly USA, LLC | $223.68 | 2023-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $206.92 | 2024-2025 | Spravato |
| Astrazeneca Pharmaceuticals Lp | $182.35 | 2024-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $163.43 | 2024-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $133.41 | 2023 | Rexulti, Abilify Maintena |
| Exact Sciences Corporation | $90.44 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $74.31 | 2025 | Repatha, Otezla |
| Baxter Healthcare | $45.88 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sumitomo Pharma America, INC. | $29.71 | 2024 | Gemtesa |
| Boston Scientific Corporation | $24.04 | 2024 | |
| Inari Medical, INC. | $23.01 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $22.28 | 2025 | |
| Pfizer INC. | $22.03 | 2025 | |
| Inspire Medical Systems, INC. | $21.85 | 2025 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.65 | 2025 | Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $17.46 | 2024 | Trelegy Ellipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.65 | 2024 | Caplyta |
| Abbvie INC. | $13.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Usman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.